NuVasive Inc. (NUVA)
NASDAQ: NUVA
· Real-Time Price · USD
39.75
-0.91 (-2.24%)
At close: Aug 31, 2023, 10:00 PM
NuVasive Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Product Revenue | 1.09B | 1.03B | 950.19M | 1.04B | 986.46M |
| Product Revenue Growth | +5.45% | +8.88% | -9.04% | +5.90% | n/a |
| Service Revenue | 110.99M | 104.38M | 100.39M | 123.46M | 115.26M |
| Service Revenue Growth | +6.33% | +3.97% | -18.68% | +7.12% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 276.08M | 876.61M | 821.82M | 941.09M | 896.15M | 853.25M | 831.72M | 620.36M |
| Non-Us Revenue Growth | -68.51% | +6.67% | -12.67% | +5.01% | +5.03% | +2.59% | +34.07% | n/a |
| United States Revenue | 925.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 163.86M | 176.19M | 159.11M | 154M | 160.7M | 160.28M | 160.68M | 146.06M | 157.4M | 145.95M | 144.26M | 146.26M | 126.44M | 130.23M | 160.37M | 152.89M | 152.85M | 145.08M | 142.2M | 141.21M | 145.66M | 146.77M | 134.5M | 125.8M | 139.11M | 140.5M | 142.41M | 131.89M | 134.49M | 130.19M | 121.73M | 111.38M | 115.32M | 116.1M |
| Selling, General, and Administrative Revenue Growth | -7.00% | +10.73% | +3.32% | -4.16% | +0.26% | -0.25% | +10.01% | -7.21% | +7.84% | +1.17% | -1.37% | +15.67% | -2.91% | -18.79% | +4.89% | +0.02% | +5.36% | +2.02% | +0.70% | -3.05% | -0.75% | +9.12% | +6.92% | -9.57% | -0.99% | -1.34% | +7.98% | -1.93% | +3.30% | +6.95% | +9.29% | -3.41% | -0.67% | n/a |
| Research and Development Revenue | 28.65M | 24.57M | 25.59M | 23.67M | 25.91M | 23.36M | 25.23M | 23.41M | 21.76M | 22.22M | 21.77M | 20.4M | 19.41M | 18.26M | 19.11M | 18.14M | 17.55M | 17.57M | 17.09M | 15.25M | 14.86M | 14.49M | 12.72M | 12.72M | 12.57M | 12.41M | 12.98M | 12.52M | 11.87M | 10.63M | 8.61M | 9.2M | 8.78M | 9.26M |
| Research and Development Revenue Growth | +16.61% | -3.96% | +8.12% | -8.67% | +10.94% | -7.43% | +7.81% | +7.54% | -2.07% | +2.08% | +6.70% | +5.14% | +6.29% | -4.46% | +5.32% | +3.36% | -0.13% | +2.81% | +12.06% | +2.68% | +2.52% | +13.93% | -0.01% | +1.18% | +1.27% | -4.38% | +3.73% | +5.43% | +11.69% | +23.51% | -6.45% | +4.75% | -5.20% | n/a |